ETHAMOLIN SUMMARY
ETHAMOLIN® (Ethanolamine Oleate) Injection is a mild sclerosing agent.
ETHAMOLIN Injection is indicated for the treatment of patients with esophageal varices that have recently bled, to prevent rebleeding.
ETHAMOLIN is not indicated for the treatment of patients with esophageal varices that have not bled. There is no evidence that treatment of this population decreases the likelihood of bleeding.
Sclerotherapy with ETHAMOLIN has no beneficial effect upon portal hypertension, the cause of esophageal varices, so that recanalization and collateralization may occur, necessitating reinjection.
|
NEWS HIGHLIGHTS
Published Studies Related to Ethamolin (Ethanolamine)
Effectiveness of the association micronized N-Palmitoylethanolamine
(PEA)-transpolydatin in the treatment of chronic pelvic pain related to
endometriosis after laparoscopic assessment: a pilot study. [2011] pelvic pain related to EMS... CONCLUSION: These preliminary results show that the association between
Administration of a dietary supplement ( N-oleyl-phosphatidylethanolamine and epigallocatechin-3-gallate formula) enhances compliance with diet in healthy overweight subjects: a randomized controlled trial. [2009.03] Many studies have found that N-oleyl-ethanolamine (NOE), a metabolite of N-oleyl-phosphatidylethanolamine (NOPE), and epigallocatechin-3-gallate (EGCG) inhibit food intake. The main aim of this study was to evaluate the efficacy of 2 months of administration of an oily NOPE-EGCG complex (85 mg NOPE and 50 mg EGCG per capsule) and its effect on compliance with diet in healthy, overweight people...
Administration of a dietary supplement ( N-oleyl-phosphatidylethanolamine and epigallocatechin-3-gallate formula) enhances compliance with diet in healthy overweight subjects: a randomized controlled trial. [2008.07.01] Many studies have found that N-oleyl-ethanolamine (NOE), a metabolite of N-oleyl-phosphatidylethanolamine (NOPE), and epigallocatechin-3-gallate (EGCG) inhibit food intake. The main aim of this study was to evaluate the efficacy of 2 months of administration of an oily NOPE-EGCG complex (85 mg NOPE and 50 mg EGCG per capsule) and its effect on compliance with diet in healthy, overweight people...
Ototoxicity of triethanolamine polypeptide (cerumenex) in the chinchilla. [2008.03] The use of earwax softeners and cerumenolytics to unblock the external auditory canal is increasing. Although reports on their effectiveness are available, data about their effect on hearing are limited. OBJECTIVE: To assess the effect of ototopic triethanolamine polypeptide oleate condensate 10% (Cerumenex) on hearing. STUDY DESIGN: Prospective, randomized, controlled trial in a chinchilla animal model... CONCLUSIONS: In the chinchilla, when a tympanic perforation is present, Cerumenex causes a reduction in DPOAE signal and damage to the cochlear hair cells. Caution should be observed when prescribing this agent if the status of the tympanic membrane is unknown. Furthermore, its use without medical prescription should be discouraged because of the risk of ototoxicity and severe inflammatory reaction.
Clinical Trials Related to Ethamolin (Ethanolamine)
Injection Snoreplasty: Comparison Between Ethanol and Ethanolamine Oleate [Active, not recruiting]
SUMMARY INTRODUCTION: among various treatments for patients with primary snoring, upper
airway resistance syndrome (UARS) and obstructive sleep apnea syndrome (OSAS), the injection
snoreplasty arose as a promising alternative in some selected cases.
OBJECTIVE: to investigate the efficacy and tolerance of injection snoreplasty comparing
Ethanol and Ethanolamine Oleate.
Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies [Withdrawn]
RATIONALE: Antimicrobial solution comprising trimethoprim-sulfamethoxazole, edetate calcium
disodium, and ethanol may help prevent blockages and infections from forming in patients
with central venous access catheters or peripheral venous catheters.
PURPOSE: This randomized trial is studying an antimicrobial solution or saline solution in
maintaining catheter patency and preventing catheter-related blood infections in patients
with malignancies.
A Randomized Controlled Trial Comparing Band Ligation and Cyanoacrylate Injection for Esophageal Varices [Completed]
Compare VBL and cyanoacrylate injection (CI) in the treatment of EV in patients with
advanced liver disease regarding eradication, bleeding, mortality, complication and
recurrence rates.
Treatment Schistosomal Portal Hypertension: Efficacy of Endoscopy or Surgery [Completed]
Upper gastrointestinal bleeding (UGIB) is a major cause of morbidity and mortality in
patients with portal hypertension secondary to schistosomiasis mansoni. Taking into account
the endemic nature of schistosomiasis mansoni in our region and the high morbidity and
mortality directly associated with rupture of esophageal varices and UGIB in affected
patients, we conducted a prospective randomized trial in patients with schistosomiasis and a
history of bleeding esophageal varices. Its purpose was to assess the efficacy of endoscopic
treatment alone compared with the efficacy of sclerotherapy preceded by a surgical
treatment: Esophagogastric devascularization with splenectomy (EGDS).
|